MyFinsight
Home
Blog
About
Marketable securities
$288,075K
(465.14%↑ Y/Y)
Cash and cash
equivalents
$32,286K
(34.49%↑ Y/Y)
Prepaid expenses and
other current assets
$6,795K
(173.22%↑ Y/Y)
Accounts receivable from
collaboration with a related...
$822K
Total current assets
$327,978K
(323.38%↑ Y/Y)
Operating lease
right-of-use (rou) assets
$2,227K
(-19.95%↓ Y/Y)
Property and equipment,
net
$315K
(43.84%↑ Y/Y)
Other assets
$312K
(0.00%↑ Y/Y)
Total assets
$330,832K
(309.55%↑ Y/Y)
Total liabilities and
stockholders' equity
$330,832K
(309.55%↑ Y/Y)
Total stockholders'
equity
$305,649K
(1588.67%↑ Y/Y)
Total liabilities
$25,183K
(-59.82%↓ Y/Y)
Accumulated deficit
-$844,983K
(-0.00%↓ Y/Y)
Accumulated other
comprehensive loss
-$623K
(-123.30%↓ Y/Y)
Additional paid-in capital
$1,151,235K
(33.35%↑ Y/Y)
Total current
liabilities
$23,445K
(-50.42%↓ Y/Y)
Operating lease
liabilities - long-term
$1,738K
(-26.07%↓ Y/Y)
Common stock, 0.001 par
value 150,000,000...
$20K
(150.00%↑ Y/Y)
Deferred revenue from a
related party
$16,304K
(-60.15%↓ Y/Y)
Other accrued
expenses
$3,342K
(-1.91%↓ Y/Y)
Accrued research and
development expenses
$2,007K
(18.69%↑ Y/Y)
Accounts payable
$1,180K
(58.82%↑ Y/Y)
Operating lease
liabilities - short-term
$612K
(14.82%↑ Y/Y)
Back
Back
Balance Sheet
ASSEMBLY BIOSCIENCES, INC. (ASMB)
ASSEMBLY BIOSCIENCES, INC. (ASMB)
source: myfinsight.com